做多

MIRO Miromatrix Medical Price Target

Miromatrix Medical Inc. engages in the development of biological human organs to solve the chronic shortage of transplantable organs.
114,000 people in the U.S. are waiting for a life-saving organ transplant, and more than half will die due to a lack of available organs.

Miromatrix Medical trial is expected to begin in the second half of 2022 and will assess the function of a bioengineered liver in humans via an external application.

if it succeeds, the opportunity to buy the stock at these prices will be history.
The Market Cap of MIRO is just 214.74Mil

On 7/19/2021 Craig Hallum brokerage Initiated Coverage with a Buy rating and a $22.00 price target

TopgOptions

DAILY HIGH-CONVICTION OPTIONS SIGNALS patreon.com/PremiumOptionsSignals
Options buy freedom24.club/SocialBookTV
RESULTS bit.ly/TG99x
CRYPTOS partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store

免责声明

这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。

TopgOptions